Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02691416Phase 4Completed
Phase 4, randomised trial of propofol injection (veterinary) in intracranial aneurysm (2 arms), sponsored by Tianjin Third Central Hospital. Primary endpoints: Evidences of Clinically Definite Oxidative Stress Confirmed by ELISA Kit, Evidences of Clinically Definite Oxidative Stress: Micronuclei and 3 more. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02691416.